159 related articles for article (PubMed ID: 2833748)
1. Heart and bone tumors in transgenic mice.
Behringer RR; Peschon JJ; Messing A; Gartside CL; Hauschka SD; Palmiter RD; Brinster RL
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2648-52. PubMed ID: 2833748
[TBL] [Abstract][Full Text] [Related]
2. Haploid male germ cells show no susceptibility to transformation by simian virus 40 large tumour antigen in transgenic mice.
Nayernia K; Samani AA; Klaproth S; Engel W
Cell Biol Int; 1998; 22(6):437-43. PubMed ID: 10328852
[TBL] [Abstract][Full Text] [Related]
3. Expression of mouse protamine 1 genes in transgenic mice.
Peschon JJ; Behringer RR; Palmiter RD; Brinster RL
Ann N Y Acad Sci; 1989; 564():186-97. PubMed ID: 2774416
[TBL] [Abstract][Full Text] [Related]
4. Rat transition nuclear protein 2 regulatory region directs haploid expression of reporter gene in male germ cells of transgenic mice.
Nayernia K; Böhm D; Topaloglu O; Schlüter G; Engel W
Mol Reprod Dev; 2001 Apr; 58(4):368-75. PubMed ID: 11241772
[TBL] [Abstract][Full Text] [Related]
5. Haploid-specific transcription of protamine-myc and protamine-T-antigen fusion genes in transgenic mice.
Stewart TA; Hecht NB; Hollingshead PG; Johnson PA; Leong JA; Pitts SL
Mol Cell Biol; 1988 Apr; 8(4):1748-55. PubMed ID: 3380096
[TBL] [Abstract][Full Text] [Related]
6. Role of the amino-terminal domain of simian virus 40 early region in inducing tumors in secretin-expressing cells in transgenic mice.
Ratineau C; Ronco A; Leiter AB
Gastroenterology; 2000 Nov; 119(5):1305-11. PubMed ID: 11054388
[TBL] [Abstract][Full Text] [Related]
7. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
8. Cardiac tumors and dysrhythmias in transgenic mice.
Steinhelper ME; Field LJ
Toxicol Pathol; 1990; 18(4 Pt 1):464-9. PubMed ID: 2151059
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.
Brinster RL; Chen HY; Messing A; van Dyke T; Levine AJ; Palmiter RD
Cell; 1984 Jun; 37(2):367-79. PubMed ID: 6327063
[TBL] [Abstract][Full Text] [Related]
10. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.
Schell TD; Knowles BB; Tevethia SS
Cancer Res; 2000 Jun; 60(11):3002-12. PubMed ID: 10850449
[TBL] [Abstract][Full Text] [Related]
11. Oncogene-induced liver neoplasia in transgenic mice.
Sandgren EP; Quaife CJ; Pinkert CA; Palmiter RD; Brinster RL
Oncogene; 1989 Jun; 4(6):715-24. PubMed ID: 2543942
[TBL] [Abstract][Full Text] [Related]
12. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
[TBL] [Abstract][Full Text] [Related]
13. Targeted expression of SV40 T antigen in the hair follicle of transgenic mice produces an aberrant hair phenotype.
Keough R; Powell B; Rogers G
J Cell Sci; 1995 Mar; 108 ( Pt 3)():957-66. PubMed ID: 7542671
[TBL] [Abstract][Full Text] [Related]
14. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.
Hanahan D
Nature; 1985 May 9-15; 315(6015):115-22. PubMed ID: 2986015
[TBL] [Abstract][Full Text] [Related]
15. Expression of SV40 T antigen under control of rabbit uteroglobin promoter in transgenic mice.
DeMayo FJ; Finegold MJ; Hansen TN; Stanley LA; Smith B; Bullock DW
Am J Physiol; 1991 Aug; 261(2 Pt 1):L70-6. PubMed ID: 1872417
[TBL] [Abstract][Full Text] [Related]
16. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
Lab Invest; 1998 Jun; 78(6):i-xv. PubMed ID: 9645768
[TBL] [Abstract][Full Text] [Related]
17. Active ras and myc oncogenes can be compatible, but Sv40 large T antigen is specifically suppressed with normal differentiation of mouse embryonic stem cells.
Suda Y; Hirai S; Suzuki M; Ikawa Y; Aizawa S
Exp Cell Res; 1988 Sep; 178(1):98-113. PubMed ID: 2457506
[TBL] [Abstract][Full Text] [Related]
18. Transgenic model of cardiac rhabdomyosarcoma formation.
Köbbert C; Möllmann C; Schäfers M; Hermann S; Baba HA; Hoffmeier A; Breithardt G; Scheld HH; Weissen-Plenz G; Sindermann JR
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1178-86. PubMed ID: 19026800
[TBL] [Abstract][Full Text] [Related]
19. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.
Haddad R; Held WA
Cancer Res; 1997 Oct; 57(20):4615-23. PubMed ID: 9377577
[TBL] [Abstract][Full Text] [Related]
20. Detection of activated c-H-ras oncogene in hepatocellular carcinomas developing in transgenic mice harboring albumin promoter-regulated simian virus 40 gene.
Lee GH; Li H; Ohtake K; Nomura K; Hino O; Furuta Y; Aizawa S; Kitagawa T
Carcinogenesis; 1990 Jul; 11(7):1145-8. PubMed ID: 2164892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
